Literature DB >> 32968625

MicroRNA-374 is a potential diagnostic biomarker for atherosclerosis and regulates the proliferation and migration of vascular smooth muscle cells.

Weihong Wang1, Fenghua Ma1, Hongyan Zhang2.   

Abstract

BACKGROUND: The occurrence and development of atherosclerosis (AS) are closely related to the abnormality of vascular smooth muscle cells (VSMCs), and multiple microRNAs (miRNAs) have been reported to participate in the pathogenesis of AS. This study explored the expression and clinical value of miR-374 in the serum of AS patients, and analyzed its effect on the proliferation and migration of VSMCs.
METHODS: The expression levels of miR-374 in the serum of 102 asymptomatic patients with AS and 89 healthy patients were detected by fluorescence quantitative PCR. The diagnostic value of miR-374 was evaluated through the receiver operating characteristic (ROC) curve. What's more, CCK-8 and Transwell assays were used to analyze the effects of miR-374 on the proliferation and migration of VSMCs.
RESULTS: The expression level of miR-374 in the serum of AS patients was significantly higher than that of the control group. At the same time, the expression of miR-374 in AS patients was positively correlated with carotid intima-media thickness (CIMT). The area under the ROC curve is 0.824. Furthermore, overexpression of miR-374 significantly promoted the proliferation and migration of VSMCs, whereas reducing miR-374 inhibited the proliferation and migration of VSMCs.
CONCLUSIONS: The high expression of miR-374 may be a potential diagnostic marker for AS, and overexpression of miR-374 may play a role in AS by promoting the proliferation and migration of VSMCs. 2020 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Atherosclerosis (AS); miR-374; migration; proliferation; vascular smooth muscle cell (VSMC)

Year:  2020        PMID: 32968625      PMCID: PMC7487406          DOI: 10.21037/cdt-20-444

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  32 in total

Review 1.  Signaling mechanisms that regulate smooth muscle cell differentiation.

Authors:  Christopher P Mack
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07       Impact factor: 8.311

Review 2.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

3.  Unbiased Profile of MicroRNA Expression in Ascending Aortic Aneurysm Tissue Appoints Molecular Pathways Contributing to the Pathology.

Authors:  Sabina Licholai; Michal Blaż; Boguslaw Kapelak; Marek Sanak
Journal:  Ann Thorac Surg       Date:  2016-05-25       Impact factor: 4.330

4.  The role and mechanism of miR-374 regulating the malignant transformation of mesenchymal stem cells.

Authors:  Zixuan Sun; Jingyan Chen; Jiao Zhang; Runbi Ji; Wenrong Xu; Xu Zhang; Hui Qian
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

5.  MiR‑30e and miR‑92a are related to atherosclerosis by targeting ABCA1.

Authors:  Zhisheng Wang; Jiayun Zhang; Songlan Zhang; Shifang Yan; Zihui Wang; Chao Wang; Xiaojiang Zhang
Journal:  Mol Med Rep       Date:  2019-02-25       Impact factor: 2.952

6.  CircRNA‑0044073 is upregulated in atherosclerosis and increases the proliferation and invasion of cells by targeting miR‑107.

Authors:  Lin Shen; Yanyan Hu; Jianwei Lou; Sen Yin; Weiling Wang; Yuanyan Wang; Yong Xia; Wei Wu
Journal:  Mol Med Rep       Date:  2019-03-06       Impact factor: 2.952

Review 7.  Notch and vascular smooth muscle cell phenotype.

Authors:  David Morrow; Shaunta Guha; Catherine Sweeney; Yvonne Birney; Tony Walshe; Colm O'Brien; Dermot Walls; Eileen M Redmond; Paul A Cahill
Journal:  Circ Res       Date:  2008-12-05       Impact factor: 17.367

Review 8.  Role of smooth muscle cells in the initiation and early progression of atherosclerosis.

Authors:  Amanda C Doran; Nahum Meller; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-14       Impact factor: 8.311

9.  Differentially expressed microRNAs in small cell lung cancer.

Authors:  Edit Miko; Zsolt Czimmerer; Eszter Csánky; Gábor Boros; Júlia Buslig; Balázs Dezso; Beáta Scholtz
Journal:  Exp Lung Res       Date:  2009-10       Impact factor: 2.459

10.  Combined prediction of miR-210 and miR-374a for severity and prognosis of hypoxic-ischemic encephalopathy.

Authors:  Zhansheng Wang; Yulu Liu; Minkun Shao; Dong Wang; Ying Zhang
Journal:  Brain Behav       Date:  2017-12-30       Impact factor: 2.708

View more
  5 in total

1.  Evaluation of Radiotherapy on miR-374 Gene Expression in Colorectal Cancer Patient Blood Samples.

Authors:  Azam Ahmadi; Mohammad Reza Bayatiani; Fatemeh Seif; Jamshid Ansari; Parisa Rashidi; Mona Moghadasi; Mobarakeh Etemadi
Journal:  Rep Biochem Mol Biol       Date:  2022-01

2.  Circulating MicroRNAs predict glycemic improvement and response to a behavioral intervention.

Authors:  Elena Flowers; Isabel Elaine Allen; Alka M Kanaya; Bradley E Aouizerat
Journal:  Biomark Res       Date:  2021-08-23

3.  In silico Prediction of miRNA Interactions With Candidate Atherosclerosis Gene mRNAs.

Authors:  Dina Mukushkina; Dana Aisina; Anna Pyrkova; Alma Ryskulova; Siegfried Labeit; Anatoliy Ivashchenko
Journal:  Front Genet       Date:  2020-11-04       Impact factor: 4.599

4.  Dysregulation Serum miR-19a-3p is a Diagnostic Biomarker for Asymptomatic Carotid Artery Stenosis and a Promising Predictor of Cerebral Ischemia Events.

Authors:  Xiaoliang Liu; Xiaojun Zheng; Ying Wang; Juan Liu
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

5.  Diagnostic and Prognostic Significance of miR-675-3p in Patients With Atherosclerosis.

Authors:  Shuangquan Wang; Wei Shao; Yang Gao; Hongwei Zhao; Deyong Du
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.